Tae Gwan Park

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tae Gwan Park: Innovator in siRNA Technology

Introduction

Tae Gwan Park is a notable inventor recognized for his contributions to the field of small interfering RNA (siRNA) technology. His innovative work focuses on enhancing gene delivery efficiency through novel multi-conjugate structures.

Latest Patents

Tae Gwan Park holds a patent for a "Multi-conjugate of siRNA and preparing method thereof." This invention relates to a multi-conjugate of siRNA, which is prepared by either direct binding of double-stranded sense/antisense siRNA monomers or through indirect covalent bonding mediated by a cross-linking agent or polymer. The method is characterized by its simplicity and efficiency, resulting in a siRNA multi-conjugate with a high molecular weight that significantly improves ionic interaction with cationic gene carriers, thereby enhancing gene delivery efficiency.

Career Highlights

Tae Gwan Park is currently associated with Kip Co., Ltd., where he continues to advance his research in the field of RNA technology. His work has implications for various applications in gene therapy and molecular biology.

Collaborations

He collaborates with talented coworkers, including Hye Jung Mok and Soo Hyeon Lee, who contribute to the innovative projects at Kip Co., Ltd.

Conclusion

Tae Gwan Park's contributions to siRNA technology exemplify the potential of innovative approaches in enhancing gene delivery systems. His work is paving the way for advancements in genetic research and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…